Pages that link to "Q36395823"
Jump to navigation
Jump to search
The following pages link to NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. (Q36395823):
Displaying 50 items.
- The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities (Q33907425) (← links)
- Structure of the Brd4 ET domain bound to a C-terminal motif from γ-retroviral integrases reveals a conserved mechanism of interaction (Q36646571) (← links)
- BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements (Q36818327) (← links)
- Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs. (Q36956610) (← links)
- Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4 (Q37079740) (← links)
- Phospho-BRD4: transcription plasticity and drug targeting (Q37424187) (← links)
- WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck (Q37520610) (← links)
- The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer (Q37735355) (← links)
- The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes (Q38606548) (← links)
- Amplification of the NSD3-BRD4-CHD8 pathway in pelvic high-grade serous carcinomas of tubo-ovarian and endometrial origin (Q38637914) (← links)
- Nonhistone Lysine Methylation in the Regulation of Cancer Pathways (Q38801008) (← links)
- H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development (Q38829055) (← links)
- The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer (Q39134084) (← links)
- Targeting Cancer Cells with BET Bromodomain Inhibitors (Q39141456) (← links)
- Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells (Q41190385) (← links)
- BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure (Q41255959) (← links)
- The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia (Q41330428) (← links)
- The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies (Q42320718) (← links)
- Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer (Q42535435) (← links)
- Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer. (Q42775768) (← links)
- Structural Mechanism of the Oxygenase JMJD6 Recognition by the Extraterminal (ET) Domain of BRD4. (Q47116460) (← links)
- Excess Translation of Epigenetic Regulators Contributes to Fragile X Syndrome and Is Alleviated by Brd4 Inhibition. (Q47132107) (← links)
- Targeting bromodomain and extraterminal proteins in breast cancer (Q47385983) (← links)
- Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis (Q47681326) (← links)
- Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3. (Q47769849) (← links)
- Backbone resonance assignments for the SET domain of human methyltransferase NSD3 in complex with its cofactor (Q48238344) (← links)
- Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes (Q49647261) (← links)
- BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells (Q50433449) (← links)
- Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation. (Q52323123) (← links)
- The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators. (Q52345656) (← links)
- Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction. (Q52596648) (← links)
- MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. (Q55279675) (← links)
- The role of histone lysine methyltransferase NSD3 in cancer (Q57177118) (← links)
- Roles of H3K36-specific histone methyltransferases in transcription: antagonizing silencing and safeguarding transcription fidelity (Q57498154) (← links)
- Common CHD8 Genomic Targets Contrast With Model-Specific Transcriptional Impacts of Haploinsufficiency (Q61448803) (← links)
- Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains (Q63979648) (← links)
- Mediator complex interaction partners organize the transcriptional network that defines neural stem cells. (Q64903148) (← links)
- BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injury. (Q64915564) (← links)
- Downregulation of NSD3 (WHSC1L1) inhibits cell proliferation and migration via ERK1/2 deactivation and decreasing CAPG expression in colorectal cancer cells. (Q64954002) (← links)
- Targeting Epigenetics in Cancer (Q89169966) (← links)
- Methylation of Aurora kinase A by MMSET reduces p53 stability and regulates cell proliferation and apoptosis (Q90256138) (← links)
- Targeting non-bromodomain chromatin readers (Q90468310) (← links)
- Histone lysine methyltransferases in biology and disease (Q90468320) (← links)
- Bromodomain biology and drug discovery (Q90468325) (← links)
- Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3 (Q91723989) (← links)
- KDM2 proteins constrain transcription from CpG island gene promoters independently of their histone demethylase activity (Q92300589) (← links)
- Whsc1 links pluripotency exit with mesendoderm specification (Q93001306) (← links)
- CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML (Q93139098) (← links)
- Targeting complexes of super-enhancers is a promising strategy for cancer therapy (Q98386380) (← links)
- Overexpression of microRNA-221 promotes the differentiation of stem cells from human exfoliated deciduous teeth to neurons through activation of Wnt/β-catenin pathway via inhibition of CHD8 (Q102073466) (← links)